Diego dos Santos Reis
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Diego dos Santos Reis has a total of 50 co-authors. Here are the top co-authors by number of shared publications:
- Vanessa Cristiane Santana Amaral
Laboratory of Pharmacology and Toxicology of Natural and Synthetic Products, BR-153 3105 Fazenda Barreiro do Meio, State University of Goiás , Anápolis, Goiás, 75393-365
5 shared publications - Elisa Flávia Luiz Cardoso Bailão
Central Campus, State University of Goiás
4 shared publications - Jamira Dias Rocha
Biotechnology Laboratory, BR-153 3105 Fazenda Barreiro do Meio, State University of Goiás , Anápolis, Goiás, 75132400
4 shared publications - Graziele Alícia Batista Caixeta
Programa de Pós-graduação em Ciências Aplicadas a Produtos para Saúde, Universidade Estadual de Goiás, Anápolis, Brazil
3 shared publications - Luciane Madureira Almeida
Biotechnology Laboratory, BR-153 3105 Fazenda Barreiro do Meio, State University of Goiás , Anápolis, Goiás, 75132400
3 shared publications - Renata Mazaro-Costa
Laboratory of Physiology and Pharmacology of Reproduction, Department of Pharmacology, Federal University of Goiás, Goiânia, GO, Brazil
3 shared publications
Latest Publications
- 11 July 2026
- Published by Oxford University Press (OUP) in Toxicology Research
- Vol. 15 (4)
Cytotoxic but not genotoxic: toxicological evaluation of the herbicide mixture S-metolachlor + flumioxazin in human cells, rodents, and bacteria
Flumioxazin and S-metolachlor are widely used in soybean cultivation and frequently co-occur in the environment due to their persistence. This study investigated the cytotoxic, genotoxic, and mutagenic potential of a commercial formulation containing this herbicide mixture using an integrated in vitro and in vivo approach. Cytotoxicity was assessed in human erythrocytes and lymphocytes, while mutagenicity was evaluated using the Ames test with Salmonella typhimurium strains TA98 and TA100, without metabolic activation. In vivo genotoxicity was examined in Wistar rats orally exposed for 28 days, followed by the comet assay in bone marrow. The mixture induced concentration-dependent cytotoxicity, with significant hemolysis (EC50 0.093 mg/mL) and reduced lymphocyte viability (IC50 0.219 mg/mL). In contrast, no genotoxic alterations were detected in bone marrow comet assay parameters (250, 500, and 1,000 mg/kg), and mutagenic activity was not confirmed according to Ames test criteria (0.06 to 18.90 mg/plate). Collectively, these findings indicate that, although the mixture exhibited marked cytotoxicity in human cells, it did not show detectable genotoxic or mutagenic effects under the specific experimental conditions tested. These conclusions should be interpreted within the limitations of the present study, particularly the use of only TA98 and TA100 strains, the absence of metabolic activation in the Ames test, and the evaluation of bone marrow as the only tissue in the in vivo comet assay. The cytotoxic effects observed at field-dose-derived concentrations suggest the importance of further ecotoxicological evaluations, particularly regarding potential risks to non-target organisms with limited detoxification capacity.
- 11 July 2026
- Published by Oxford University Press (OUP) in Toxicology Research
- Vol. 15 (4)
Cytotoxic but not genotoxic: toxicological evaluation of the herbicide mixture S-metolachlor + flumioxazin in human cells, rodents, and bacteria
Flumioxazin and S-metolachlor are widely used in soybean cultivation and frequently co-occur in the environment due to their persistence. This study investigated the cytotoxic, genotoxic, and mutagenic potential of a commercial formulation containing this herbicide mixture using an integrated in vitro and in vivo approach. Cytotoxicity was assessed in human erythrocytes and lymphocytes, while mutagenicity was evaluated using the Ames test with Salmonella typhimurium strains TA98 and TA100, without metabolic activation. In vivo genotoxicity was examined in Wistar rats orally exposed for 28 days, followed by the comet assay in bone marrow. The mixture induced concentration-dependent cytotoxicity, with significant hemolysis (EC50 0.093 mg/mL) and reduced lymphocyte viability (IC50 0.219 mg/mL). In contrast, no genotoxic alterations were detected in bone marrow comet assay parameters (250, 500, and 1,000 mg/kg), and mutagenic activity was not confirmed according to Ames test criteria (0.06 to 18.90 mg/plate). Collectively, these findings indicate that, although the mixture exhibited marked cytotoxicity in human cells, it did not show detectable genotoxic or mutagenic effects under the specific experimental conditions tested. These conclusions should be interpreted within the limitations of the present study, particularly the use of only TA98 and TA100 strains, the absence of metabolic activation in the Ames test, and the evaluation of bone marrow as the only tissue in the in vivo comet assay. The cytotoxic effects observed at field-dose-derived concentrations suggest the importance of further ecotoxicological evaluations, particularly regarding potential risks to non-target organisms with limited detoxification capacity.
- Open Access
- 19 May 2026
- Published by Elsevier in Chemico-Biological Interactions
- Vol. 435, 112151
Reproductive toxicity induced by a repeated 28-day oral exposure to a commercial mixture of the herbicides S-metolachlor and flumioxazin in male rats
- 19 May 2026
- Published by Elsevier in Chemico-Biological Interactions
- Vol. 435, 112151
Open AccessReproductive toxicity induced by a repeated 28-day oral exposure to a commercial mixture of the herbicides S-metolachlor and flumioxazin in male rats
- 3 November 2025
- Published by Springer Nature in Revista Brasileira de Farmacognosia
- Vol. 35 (6) , 1447-1457
Prenatal Safety Evaluation of a Standardized Dry Extract of Eugenia uniflora Leaves: Dissociation between Maternal Toxicity and Fetal Outcomes in Wistar Rats
- 3 November 2025
- Published by Springer Nature in Revista Brasileira de Farmacognosia
- Vol. 35 (6) , 1447-1457
Prenatal Safety Evaluation of a Standardized Dry Extract of Eugenia uniflora Leaves: Dissociation between Maternal Toxicity and Fetal Outcomes in Wistar Rats
- 23 September 2025
- Published by Wiley in Birth Defects Research
- Vol. 117 (9) , e2526
Toxicological Assessment of a Standardized Dry Extract of Zea mays L. (Poaceae) Stigmas During Gestation: Effects on Maternal Parameters and Fetal Outcomes in Wistar Rats
Background: Corn (Zea mays L., Poaceae) stigmas, popularly known as corn silk, have been traditionally used for their diuretic properties and to treat urinary tract disorders and hypertension. Although several studies have reported beneficial effects, such as anti‐inflammatory and antioxidant activities, data on their safety during pregnancy remain limited. This study aimed to evaluate the effects of prenatal treatment with a standardized dry corn silk extract on maternal and fetal toxicity parameters in Wistar rats.Methods: Corn silk was extracted with 41% (v/v) ethanol, concentrated, and spray‐dried. The total flavonoid content was determined by spectrophotometry, and phenolic compounds, including maysin, were analyzed using HPLC‐DAD and HPLC‐ESI‐MS/MS. Pregnant Wistar rats (n = 10/group) received the vehicle or extract doses of 300, 600, or 1200 mg/kg from gestational Day (GD) 0–20. Clinical signs of toxicity, body weight gain, and food and water intake were monitored. On GD 21, blood samples were collected for biochemical analysis. Reproductive performance and genotoxicity were assessed, along with histopathological examinations of selected organs.Results: The extract contained 1.698% flavonoids, including maysin as the predominant one. No clinical signs of toxicity, changes in body weight gain, water and food intake, genotoxicity, histopathological alterations, or biochemical disturbances were observed. However, the 1200 mg/kg dose increased pre‐implantation losses. No external, skeletal, or visceral malformations were detected in fetuses.Conclusions: Under these experimental conditions, the extract did not induce maternal or fetal toxicity. Nevertheless, the 1200 mg/kg dose may interfere with early pregnancy in Wistar rats.
- 23 September 2025
- Published by Wiley in Birth Defects Research
- Vol. 117 (9) , e2526
Toxicological Assessment of a Standardized Dry Extract of Zea mays L. (Poaceae) Stigmas During Gestation: Effects on Maternal Parameters and Fetal Outcomes in Wistar Rats
Background: Corn (Zea mays L., Poaceae) stigmas, popularly known as corn silk, have been traditionally used for their diuretic properties and to treat urinary tract disorders and hypertension. Although several studies have reported beneficial effects, such as anti‐inflammatory and antioxidant activities, data on their safety during pregnancy remain limited. This study aimed to evaluate the effects of prenatal treatment with a standardized dry corn silk extract on maternal and fetal toxicity parameters in Wistar rats.Methods: Corn silk was extracted with 41% (v/v) ethanol, concentrated, and spray‐dried. The total flavonoid content was determined by spectrophotometry, and phenolic compounds, including maysin, were analyzed using HPLC‐DAD and HPLC‐ESI‐MS/MS. Pregnant Wistar rats (n = 10/group) received the vehicle or extract doses of 300, 600, or 1200 mg/kg from gestational Day (GD) 0–20. Clinical signs of toxicity, body weight gain, and food and water intake were monitored. On GD 21, blood samples were collected for biochemical analysis. Reproductive performance and genotoxicity were assessed, along with histopathological examinations of selected organs.Results: The extract contained 1.698% flavonoids, including maysin as the predominant one. No clinical signs of toxicity, changes in body weight gain, water and food intake, genotoxicity, histopathological alterations, or biochemical disturbances were observed. However, the 1200 mg/kg dose increased pre‐implantation losses. No external, skeletal, or visceral malformations were detected in fetuses.Conclusions: Under these experimental conditions, the extract did not induce maternal or fetal toxicity. Nevertheless, the 1200 mg/kg dose may interfere with early pregnancy in Wistar rats.
- Open Access
- 1 January 2022
- Published by FapUNIFESP (SciELO) in Acta Cirurgica Brasileira
- Vol. 37 (10) , e371001
Tissue healing changes on wounds in rats after treatment with Hancornia speciosa latex in cream-gel formulation
Hancornia speciosa latex has shown pharmacological potential in wound healing processes due to its angiogenic, osteogenic, and anti-inflammatory activities. The aims of this study were to carry out a cream-gel formulation with 5, 10 and 25% of H. speciosa serum latex and to evaluate its potential to stimulate the skin regeneration in rats’ wounds. One hundred and twenty rats were divided into five groups: neutral control with saline (G1), cream-gel based on H. speciosa latex serum at 5% m/v (G2), cream-gel at 15% m/v (G3), cream-gel at 25% m/v (G4), and cream-gel (G5). The animals were euthanized at three, seven, 14 and 21 days after the injury induction, and some parameters were analyzed: wound contraction, necrosis, fibrin, polymorphonuclear and mononuclear infiltrates, fibroblast, angiogenesis, hemorrhage, and collagen. The therapeutic treatment with cream-gel at 15 and 25% is beneficial in the inflammatory phase of healing processes since it increased the angiogenesis and proliferation of mononuclear infiltrations in wounds. Regarding wound contraction, the treatment with cream-gel (5 and 15%) induced a higher rate of contraction in the proliferative phase. The 15% cream-gel formulation stimulated a greater production of collagen in the injured tissues. H. speciosa cream-gel is a low-cost herbal medicine which can aid in tissue repair.
- 1 January 2022
- Published by FapUNIFESP (SciELO) in Acta Cirurgica Brasileira
- Vol. 37 (10) , e371001
Open AccessTissue healing changes on wounds in rats after treatment with Hancornia speciosa latex in cream-gel formulation
Hancornia speciosa latex has shown pharmacological potential in wound healing processes due to its angiogenic, osteogenic, and anti-inflammatory activities. The aims of this study were to carry out a cream-gel formulation with 5, 10 and 25% of H. speciosa serum latex and to evaluate its potential to stimulate the skin regeneration in rats’ wounds. One hundred and twenty rats were divided into five groups: neutral control with saline (G1), cream-gel based on H. speciosa latex serum at 5% m/v (G2), cream-gel at 15% m/v (G3), cream-gel at 25% m/v (G4), and cream-gel (G5). The animals were euthanized at three, seven, 14 and 21 days after the injury induction, and some parameters were analyzed: wound contraction, necrosis, fibrin, polymorphonuclear and mononuclear infiltrates, fibroblast, angiogenesis, hemorrhage, and collagen. The therapeutic treatment with cream-gel at 15 and 25% is beneficial in the inflammatory phase of healing processes since it increased the angiogenesis and proliferation of mononuclear infiltrations in wounds. Regarding wound contraction, the treatment with cream-gel (5 and 15%) induced a higher rate of contraction in the proliferative phase. The 15% cream-gel formulation stimulated a greater production of collagen in the injured tissues. H. speciosa cream-gel is a low-cost herbal medicine which can aid in tissue repair.